Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy

In the article “Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy” by Karaa et al.,¹ the supplemental figure was incorrectly referenced in the text. Figure e-1 should be referenced after table 1 under “Efficacy findings” on page e1215, and the first sentence on page e1216 should read: “…with the greatest apparent benefit for participants with a relatively shorter distance walked at baseline in a dose-dependent manner (data not shown; figure e-1, links.lww.com/WNL/A308).” The authors regret the error.